Researchers are developing genomic screening tools to tailor radiation dose and hormone therapy for prostate cancer patients, ...
Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all ...
A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise's core biological effects ...
Diabetes drug metformin may mimic exercise effects in prostate cancer, supporting weight, metabolism and overall health ...
With the campaign, Highlights REAL, they are spotlighting the everyday experiences of advanced prostate cancer patients and ...
Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...
Shares of Oric Pharmaceuticals fell after the company said data from a phase 1b trial of a prostate cancer treatment showed that a larger dose led to higher rates of side effects. Shares were down 22% ...
The main advantage of proton therapy is its precision. Protons deposit most of their energy directly in the tumor with little ...
India, April 2 -- Men with early-stage metastatic prostate cancer may soon be able to postpone the debilitating side effects ...
In late March 2026, ORIC Pharmaceuticals reported Phase 1b data showing that rinzimetostat 400 mg once daily plus darolutamide in post-abiraterone metastatic castration-resistant prostate cancer ...
A study found microplastics in prostate tumors, with higher levels in cancer tissue, prompting further research into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results